Dadi Segal

Cannabis-focused pharma company Panaxia Labs Israel (TASE:PNAX) (OTCEM:PXLIF) and a subsidiary of Panaxia Global, together with Neuraxpharm Group announced Monday a first export of medical cannabis sublingual tablets from Israel to France. Neuraxpharm is a European specialty pharmaceutical company...

Panaxia Global (TASE: PNAX), which owns medical cannabis company Panaxia Labs Israel Ltd., has obtained official authorization from the EU Health Authority for the EU-GMP standard for its production facility in Malta. This standard, which is binding and essential for the production...

Medical cannabis producer Panaxia Labs Israel Ltd. (TASE: PNAX), a subsidiary of Panaxia Global (TASE: PNAX) and Neuraxpharm, a European company that specializes in the central nervous system have launched sales of medical cannabis extracts under the joint Brand: Naxiva-Panaxol...

Medical cannabis company Panaxia Labs Israel Ltd., a subsidiary of Panaxia Global (TASE: PNAX), reported its financial results on Monday for the third quarter revealing revenues of NIS22.5 million ($7.15 million), up by 34% from NIS16.8 million in the same period of last year. The...

Panaxia Labs Israel Ltd. (TASE: PNAX) (OTCPK: PXLIF) a subsidiary of Panaxia Global released its financial reports on Thursday for the second quarter and first half of 2021, revealing second-quarter revenues of NIS17.6 million ($5.49 million), up by 19.2% from NIS14.8 million in the same quarter of...

Israel's largest manufacturer and home-delivery distributor of medical cannabis products, Panaxia Labs Israel Ltd., and its German partner Neuraxpharm received the green light to market and distribute medical cannabis extracts for inhalation, making them the first to...